Jane Street’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Jane Street’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,500	Closed	-$100K	–	11030
2021 Q3	$100K	Sell	20,500 -9,100	-31%	-$50.1K	﹤0.01%	9297
2021 Q2	$202K	Buy	+29,600	New	+$239K	﹤0.01%	8809

Jane Street's PRTK Position: Q3 2023 in Review

Jane Street sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 14,668 shares — an estimated $32.4K sold.

Jane Street first reported a position in PRTK in Q2 2013 and held it in 13 quarters. The position peaked at $201K in Q2 2021. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Jane Street reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Jane Street sold 14,668 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $32.4K.
Jane Street first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
Jane Street's Paratek Pharmaceuticals, Inc. position peaked at $201K in Q2 2021.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.